Bairaha Farms PlcCSELK: BFL.N0000

Interim Financial Statements as at 30th September 2025

Oct 23, 2025 at 3:37 AM UTC · Issued by Bairaha Farms Plc

‌BAIRAHA FARMS PLC.

FINANCIAL STATEMENTS 30TH SEPTEMBER 2025

‌Bairaha Farms Plc

For the quarter ended 30 September 2025, Bairaha Farms PLC recorded a net profit of Rs. 425 Mn, compared to a loss of Rs. 109 Mn reported for the corresponding quarter in the last year. The cumulative profit for the six-month period stood at Rs. 403 million, marking a significant turnaround from the profit of Rs. 38 Mn recorded in the same period of the previous year. This improvement reflects a notable recovery in market conditions, with prices of live birds and day-old chicks gradually increasing from June and peaking in September. During this period, the industry also witnessed a gradual reduction in day-old chick and live bird output due to several factors, including lower average weights in broiler birds arising from feed quality issues in using poor quality of locally sourced maize, as well as a reduction in parent stock placements. These developments contributed to a tightening of supply, supporting the upward movement in prices.

Despite the improved market environment, the industry continued to face challenges in feed quality. Although imports of maize were permitted during the quarter, the locally purchased maize of inferior quality and procured at higher prices had to be utilized first. These circumstances adversely affected profitability of the feed milling operation. Consequently, the overall share of joint venture profit declined, from Rs. 192 Mn in the first six months of last year to a loss of Rs. 12 Mn for the corresponding period of 2025.

The company continues to focus on enhancing operational efficiency and maintaining product quality, while proactively managing supply chain challenges. We remain confident that our strategic initiatives and experience in the industry will enable us to sustain growth momentum and continue to deliver value to our shareholders.

(sgd.) Yakooth Naleem Managing Director

22/10/2025

Bairaha Farms PLC

Statement of Financial Position As at 30th September 2025

Group Company

	Unaudited as at	Unaudited as at	Audited as at	Unaudited as at	Unaudited as at	Audited as at
	30.09.2025	30.09.2024	31.03.2025	30.09.2025	30.09.2024	31.03.2025
	Rs	Rs	Rs	Rs	Rs	Rs
ASSETS
Non-Current Assets
Property, Plant & Equipment	4,045,089,335	3,776,646,658	3,868,961,731	1,444,981,691	1,290,415,425	1,341,250,215
Right of use Assets	19,377,821	25,732,263	22,873,122	29,486,637	37,911,393	33,699,015
Investment Property	-	-	-	43,828,729	46,144,169	44,986,449
Intangible Assets	23,878,770	29,137,791	26,492,233	23,023,020	28,175,041	25,582,984
Investments in Subsidiaries	-	-	-	392,566,960	388,532,820	392,566,960
Investments in Joint Ventures	2,069,184,234	2,109,445,164	2,081,190,594	711,922,000	711,922,000	711,922,000
Other Investments	919,287	788,900	919,287	919,287	788,900	919,287
Biological Assets- Bearer	112,191,507	103,999,590	131,113,400	112,191,507	103,999,590	131,113,400
	6,270,640,954	6,045,750,366	6,131,550,367	2,758,919,831	2,607,889,338	2,682,040,310
Current Assets
Inventories	753,210,741	810,610,184	692,451,688	566,509,498	636,734,422	521,262,380
Biological Assets- Consumable	543,006,325	505,299,749	522,874,978	543,006,325	505,299,749	522,874,978
Biological Assets- Bearer	918,787,529	913,350,436	914,643,909	918,787,529	913,350,436	914,643,909
Trade and Other Receivables	1,182,312,427	1,098,464,887	1,139,245,507	1,327,684,023	1,200,400,675	1,270,868,166
Income Tax Receivable	-	22,183,436	21,058,319	-	12,186,937	11,408,322
Other Investments	25,596,662	25,563,201	25,596,662	96,662	63,201	96,662
Amounts Due from Related Parties	6,585,633	23,419,972	939,883	872,355,955	552,128,316	803,178,315
Cash and Bank Balances	408,025,091	285,961,976	381,797,129	193,861,494	173,942,608	202,470,042
	3,837,524,409	3,684,853,841	3,698,608,075	4,422,301,487	3,994,106,344	4,246,802,775
Total Assets	10,108,165,363	9,730,604,207	9,830,158,442	7,181,221,318	6,601,995,682	6,928,843,085
EQUITY AND LIABILITIES
Equity
Stated Capital	536,305,197	536,305,197	536,305,197	536,305,197	536,305,197	536,305,197
Revaluation Surplus	1,105,419,247	1,105,419,247	1,105,419,247	288,119,507	288,119,507	288,119,507
Fair Value Reserve	(1,226,708)	(1,357,107)	(1,226,708)	(1,226,708)	(1,357,107)	(1,226,708)
Actuarial Gain on Defined Benefit Plans	(6,335,221)	(7,299,464)	(6,335,221)	(6,335,221)	(7,299,464)	(6,335,221)
Foreign Currency Translation Reserve	576,762	-	(173,117)	-	-	-
Retained Earnings	4,619,823,517	4,169,423,030	4,212,592,458	759,914,207	324,965,754	391,076,840
Total equity attributable to equity holders of the company	6,254,562,793	5,802,490,903	5,846,581,856	1,576,776,982	1,140,733,887	1,207,939,615
Non-Controlling Interest	(7,329,014)	-	(3,009,235)	-	-	-
Total Equity	6,247,233,779	5,802,490,903	5,843,572,621	1,576,776,982	1,140,733,887	1,207,939,615
Non-Current Liabilities
Financing & Lease (Ijara) Payable	422,513,611	317,240,200	544,174,170	148,364,360	181,196,687	149,646,751
Deferred Tax Liabilities	453,584,246	470,783,967	453,584,247	117,839,495	163,834,712	117,839,495
Retirement Benefit Liability	187,028,073	164,293,737	173,674,460	161,798,010	144,828,264	151,387,760
	1,063,125,929	952,317,904	1,171,432,877	428,001,865	489,859,663	418,874,006
Current Liabilities
Trade and Other Payables	1,030,126,399	724,366,809	1,087,222,617	3,552,651,811	2,835,060,900	3,617,651,127
Dividends Payable	9,532,724	9,039,979	13,947,386	9,532,724	9,039,979	13,947,386
Amounts Due to Related Parties	-	-	-	4,529,002	-	41,100,586
Income Tax Payable	21,488,485	-	-	27,341,855	-	-
Financing & Lease (Ijara) Payable	1,736,658,046	2,242,388,612	1,713,982,941	1,582,387,080	2,127,301,253	1,629,330,365
	2,797,805,654	2,975,795,400	2,815,152,944	5,176,442,472	4,971,402,132	5,302,029,464
Total Equity and Liabilities	10,108,165,363	9,730,604,207	9,830,158,442	7,181,221,318	6,601,995,682	6,928,843,085
The above figures are provisional and subject to audit.

I certify that the above Financial Statements have been prepared in compliance with the reqirements of the Companies Act No. 07 of 2007.

Sgd: Mr. Shafraz Hussaindeen Chief Financial Officer

The Board of Directors is responsible for the preparation and presentation of these Financial Statements.

Sgd: Mr. Yakooth Naleem Sgd: Mr. Riyal Yakoob

Managing Director Executive Director

22-Oct-2025

Statement of Profit or Loss and Other Comprehensive Income - Group

For the Six Months ended 30th September 2025

Unaudited for the six months ended 30.09.2025

Unaudited for the six months ended 30.09.2024

Unaudited for the quarter ended 30.09.2025

Unaudited for the quarter

ended 30.09.2024

Group Change

Rs Rs Rs Rs +/(-)

Revenue	7,688,521,277	6,625,535,968	4,233,805,360	3,232,026,315	16
			-
Cost of Sales	(6,305,596,401)	(5,785,086,734)	(3,291,217,566)	(2,922,336,374)	9
Gross Profit	1,382,924,876	840,449,234	942,587,794	309,689,941	65
Other Operating Income	20,891,340	14,382,236	12,465,233	243,230	45
			-
Distribution Costs	(428,325,045)	(456,930,810)	(228,871,635)	(232,868,523)	(6)
			-
Administrative Expenses	(430,171,060)	(383,825,618)	(255,770,049)	(189,338,900)	12
			-
Other Operating Expenses	1,789,218	(8,538,117)	1,789,218	(5,484,952)	121
			-
Finance Cost	(87,414,855)	(148,008,022)	(35,731,971)	(72,087,175)	(41)
Profit before Tax	459,694,475	(142,471,097)	436,468,590	(189,846,379)	423
Share of Profit from Joint Venture Companies	(12,006,348)	191,683,059	32,865,063	74,062,314	(106)
			-
Income Tax Expense	(44,776,848)	(11,215,821)	(44,776,848)	6,581,096	299
Profit for the Period	402,911,279	37,996,141	424,556,805	(109,202,970)	960
Other Comprehensive Income	-	-	-	-
Total Comprehensive Income	402,911,279	37,996,141	424,556,805	(109,202,970)	960
Profit/ (Loss) Attributable to :
Equity Holders of the Parent	407,231,059	37,996,141	427,996,744	(109,202,970)	972
Non-Controlling Interest	(4,319,780)	-	(3,439,939)	-	(100)
	402,911,279	37,996,141	424,556,805	(109,202,970)	960
Total Comprehensive Income Attributable to : Equity Holders of the Parent	407,231,059	37,996,141	427,996,744	(109,202,970)	972
Non-Controlling Interest	(4,319,780)	-	(3,439,939)	-	(100)
	402,911,279	37,996,141	424,556,805	(109,202,970)	960
Earnings per Share - Basic	23.14	2.16	24.32	(6.20)	972
The above figures are provisional and subject to audit.

I certify that the above Financial Statements have been prepared in compliance with the reqirements of the Companies Act No. 07 of 2007.

Sgd: Mr. Shafraz Hussaindeen Chief Financial Officer

The Board of Directors is responsible for the preparation and presentation of these Financial Statements.

Sgd: Mr. Yakooth Naleem Sgd: Mr. Riyal Yakoob

Managing Director Executive Director

22-Oct-2025

Statement of Profit or Loss and Other Comprehensive Income - Company

For the Six Months ended 30th September 2025

Unaudited for the six months ended 30.09.2025

Unaudited for the six months ended 30.09.2024

Unaudited for the quarter ended 30.09.2025

Unaudited for the quarter

ended 30.09.2024

Group Change

Rs Rs Rs Rs +/(-)

Revenue	6,703,827,985	6,089,512,422	3,681,075,839	3,013,777,951	10
Cost of Sales	(5,589,961,216) (5,470,273,747) (2,871,677,884) (2,814,480,348)				2
Gross Profit	1,113,866,770	619,238,675	809,397,955	199,297,603	80
Other Operating Income	29,974,091	86,769,656	10,649,193	22,826,565	(65)
				-
Distribution Costs	(311,870,550)	(390,118,154)	(159,349,732)	(199,984,261)	(20)
				-
Administrative Expenses	(344,879,429)	(289,188,804)	(205,858,096)	(143,073,366)	19
				-
Other Operating Expenses	1,789,218	(8,538,117)	1,789,218	(5,484,952)	121
Finance Cost	(80,483,947)	(122,062,630)	(39,699,204)	- (57,894,018)	(34)
Profit before Tax	408,396,153	(103,899,374)	416,929,333	(184,312,429)	493
Income Tax Expense	(39,558,786)	(5,104,013)	(39,558,786)	7,765,248	675
Profit for the Period	368,837,367	(109,003,387)	377,370,547	(176,547,181)	438
Other Comprehensive Income	-	-	-	-
Total Comprehensive Income	368,837,367	(109,003,387)	377,370,547	(176,547,181)	438
				.
Earnings per Share - Basic	20.96	(6.19)	21.44	(10.03)	438
The above figures are provisional and subject to audit.

I certify that the above Financial Statements have been prepared in compliance with the reqirements of the Companies Act No. 07 of 2007.

Sgd: Mr. Shafraz Hussaindeen -

Chief Financial Officer

The Board of Directors is responsible for the preparation and presentation of these Financial Statements.

Sgd: Mr. Yakooth Naleem Sgd: Mr. Riyal Yakoob

Managing Director Executive Director

22-Oct-2025

Statement of Changes in Equity

For the Six Months ended 30th September 2025

	Stated	Revaluation	Fair Value Actuarial Gain		Foreign	Retained	Total Equity	Non	Total
	Capital	Surplus	Reserve	on Defined	Currency	Earnings	Holders'	Controlling
				Benefit Plans	Translation		Funds	Interest
					Reserve
	Rs	Rs	Rs	Rs	Rs	Rs	Rs	Rs	Rs
Group Balance as at 1st April 2024	536,305,197	1,105,419,247	(1,357,107)	(7,299,464)	-	4,175,426,889	5,808,494,762	-	5,808,494,762
Profit for the Six months ended 30th September 2024	-	-	-	-	-	37,996,141	37,996,141	-	37,996,141
Dividends	-	-	-	-	-	(44,000,000)	(44,000,000)	-	(44,000,000)
Balance as at 30th September 2024	536,305,197	1,105,419,247	(1,357,107)	(7,299,464)	-	4,169,423,030	5,802,490,903	-	5,802,490,903
Company Balance as at 1st April 2024	536,305,197	288,119,507	(1,357,107)	(7,299,464)	-	477,969,141	1,293,737,274	-	1,293,737,274
Profit for the Six months ended 30th September 2024	-	-	-	-	-	(109,003,387)	(109,003,387)		(109,003,387)
Dividends	-	-	-	-	-	(44,000,000)	(44,000,000)		(44,000,000)
Balance as at 30th September 2024	536,305,197	288,119,507	(1,357,107)	(7,299,464)	-	324,965,755	1,140,733,887	-	1,140,733,887
Group Balance as at 1st April 2025	536,305,197	1,105,419,247	(1,226,708)	(6,335,221)	(173,117)	4,212,592,458	5,846,581,856	(3,009,235)	5,843,572,621
Profit for the Six months ended 30th September 2025	-	-	-	-	749,879	407,231,059	407,980,938	(4,319,780)	403,661,158
Dividends	-	-	-	-	-	-	-	-	-
Balance as at 30th September 2025	536,305,197	1,105,419,247	(1,226,708)	(6,335,221)	576,762	4,619,823,517	6,254,562,793	(7,329,014)	6,247,233,779
Company Balance as at 1st April 2025	536,305,197	288,119,507	(1,226,708)	(6,335,221)	-	391,076,840	1,207,939,615	-	1,207,939,615
Profit for the Six months ended 30th September 2025	-	-	-	-	-	368,837,367	368,837,367	-	368,837,367
Dividends	-	-	-	-	-	-	-	-	-
Balance as at 30th September 2025	536,305,197	288,119,507	(1,226,708)	(6,335,221)	-	759,914,207	1,576,776,982	-	1,576,776,982

Cash Flow Statement

For the Six Months ended 30th September 2025

	Group		Company
	Unaudited for the six months ended 30.09.2025	Unaudited for the six months ended 30.09.2024	Unaudited for the six months ended 30.09.2025	Unaudited for the six months ended 30.09.2024
	Rs	Rs	Rs	Rs
Cash Flows From/(Used in) Operating Activities
Net Profit before Income Tax Expense	459,694,475	(142,471,097)	408,396,153	(103,899,374)
Adjustments for
Allowance for Weight Loss	80,977,340	107,103,304	80,977,340	107,103,304
Depreciation	175,758,648	154,109,091	82,893,123	72,601,795
Right of use Asset Depreciation	3,495,300	2,859,141	4,212,378	4,212,377
Intangible Assets Amortization	2,613,463	2,622,306	2,559,964	2,592,057
Income from Investments	-	-	-	(51,795,071)
Profit on Disposal of Property, Plant & Equipment	-	-	-	-
Finance Cost	87,414,855	148,008,022	80,483,947	122,062,630
Provision for Defined Benefit Plans	19,183,111	17,140,000	15,000,000	15,000,000
Allowance for Bad & Doubtful Debts	13,996,688	-	13,996,688	-
Operating Profit before Working Capital Changes	843,133,879	289,370,766	688,519,592	167,877,719
(Increase)/ Decrease in Inventories	(141,736,393)	(310,338,247)	(126,224,458)	(287,744,513)
(Increase)/ Decrease in Biological Assets	(24,274,967)	38,643,841	(24,274,967)	38,643,841
(Increase)/ Decrease in Trade and Other Receivables	(57,063,609)	112,160,869	(70,812,544)	133,791,426
Increase/ (Decrease) in Related Company Balances (Net)	(5,645,750)	(13,959,256)	(105,749,218)	(439,517,096)
Increase/ (Decrease) in Trade and Other Payables	(56,346,324)	155,538,851	(64,999,324)	457,914,038
Cash Generated from Operations	558,066,837	271,416,824	296,459,082	70,965,414
Finance Costs Paid	(87,414,855)	(148,008,022)	(80,483,947)	(122,062,630)
Defined Benefit Plan Costs Paid	(5,829,500)	(3,862,444)	(4,589,750)	(3,294,944)
Income Tax Paid	(2,230,046)	(15,487,452)	(808,610)	(8,371,675)
Net Cash Flows From Operating Activities	462,592,436	104,058,906	210,576,776	(62,763,835)
Cash Flows from /(Used in) Investing Activities
Acquisition of Property, Plant & Equipment	(358,036,251)	(184,476,463)	(191,616,879)	(125,335,140)
Dividend Received	-	16,375,000	-	51,795,071
Proceeds from Sale of Property, Plant & Equipment	6,150,000	-	6,150,000	-
Net Acquisition of Biological Assets	18,921,893	1,440,711	18,921,893	1,440,711
Acquisition of Intangible Assets	-	(930,000)	-	-
Net Cash Flows Used in Investing Activities	(332,964,358)	(167,590,751)	(166,544,986)	(72,099,357)
Cash Flows from (Used in) Financing Activities
Dividend Paid	(4,414,661)	(43,222,196)	(4,414,661)	(43,222,196)
Proceeds From Financing and Lease (Ijara)	46,100,000	175,100,000	46,100,000	140,100,000
Repayment of Financing Payable	(181,814,540)	(69,323,329)	(136,236,749)	(21,687,499)
Net Cash Flows From Financing Activities	(140,129,202)	62,554,474	(94,551,411)	75,190,305
Net Increase/(Decrease) in Cash and Cash Equivalents	(10,501,124)	(977,371)	(50,519,621)	(59,672,888)
Cash and Cash Equivalents at the Beginning of the Period	144,439,136	98,288,094	(29,705,965)	44,964,244
Cash and Cash Equivalents at the End of the Period	133,938,012	97,310,723	(80,225,586)	(14,708,644)
Breakup of Cash and Cash Equivalents at the End of the Period
Cash and Bank Balances	408,025,091	285,961,976	193,861,494	173,942,608
Express Cash Funding (Bank Overdraft)	(274,087,080)	(188,651,252)	(274,087,080)	(188,651,252)
	133,938,012	97,310,723	(80,225,586)	(14,708,644)

Notes to the Financial Statements

For the Six Months ended 30th September 2025

1 Accounting Policies

The Consolidated Financial Statements were prepared using the same accounting policies and methods of computation that were applied to prepare the Audited Consolidated Financial Statements for the year ended

31 March 2025 and are in compliance with Sri Lanka Accounting Standard (LKAS) 34 - Interim Financial Reporting.

	As at	As at
2 Net Asset Value per Share (Rs.)	30.09.2025	30.09.2024
	354.96	329.69
	Quarter 01.07.2025 to	Quarter 01.07.2024 to
3 Market Value per share during the Quarter ( Rs.)	30.09.2025	30.09.2024
Highest	374.00	172.00
Lowest	192.00	150.00
Closing	360.25	163.75
	As at	As at
4 Ordinary Shares ( No's )	30.09.2025	30.09.2024
Fully paid ordinary shares	17,600,000	17,600,000

There are no events / circumstances that have arisen since the reporting date which would require adjustments to or disclosure in the financial statements.

There have been no material changes to the contingent assets or contingent liabilities since the last annual reporting period.

Additional Notes to the Financial Statements For the Six Months ended 30th September 2025

Thirty Major Shareholders as at 30th September 2025

Name No. of Shares %

1 Mr. M.N.M. Yakooth	1,872,053	10.64%
2 Mr. M.N.M. Mubarak	1,826,998	10.38%
3 Mr. M.N.M. Kamil	1,764,316	10.02%
4 Mrs. F.S. Imran	992,251	5.64%
5 Mr. M.Y.M. Riyal	906,735	5.15%
6 Deutsche Bank Ag-National Equity Fund	625,382	3.55%
7 Mr. M.E.N. Mohamed Ilyas	590,059	3.35%
8 Mr. M.I. Ilyas Naleem	590,035	3.35%
9 Amana Bank Plc/Hi-Line Trading Pvt Ltd	385,076	2.19%
10 Seylan Bank Plc/K.L.G.Udayananda	334,377	1.90%
11 Seylan Bank Plc/S.R. Fernando	303,492	1.72%
12 Mrs. F.F. Ilyas Naleem	295,016	1.68%
13 Employees Trust Fund Board	237,216	1.35%
14 Est.of Late F.I. Mohamed Rauff	210,727	1.20%
15 Seylan Bank Plc/R.A.Rishard	190,000	1.08%
16 Seylan Bank Plc/Mohamed Mushtaq Fuad	179,136	1.02%
17 People'S Leasing & Finance Plc/Hi Line Trading (Pvt) Ltd	165,259	0.94%
18 People S Leasing And Finance Plc/M.E.Amarasinghe	160,200	0.91%
19 Hatton National Bank Plc-Senfin Growth Fund	143,000	0.81%
20 Mr. M.Z. Rasheed	135,600	0.77%
21 People'S Leasing & Finance Plc/K.L.Udayananda	129,128	0.73%
22 Mr. R. Pestonjee	108,938	0.62%
23 M.T.A. Furkhan Foundation	105,635	0.60%
24 Bank Of Ceylon No. 1 Account	100,000	0.57%
25 Mr. K.L. Yeoh	90,751	0.52%
26 Deutsche Bank Ag-Namal Growth Fund	90,000	0.51%
27 People'S Leasing & Finance Plc/Hi Line Towers (Pvt) Ltd	88,070	0.50%
28 Senkadagala Finance Plc/M.M.Fuad	86,891	0.49%
29 Mr. M.R. Rasheed	85,700	0.49%
30 Mr. A.M.A. Alsaad	83,725	0.48%
	12,875,766	73.16%
Others	4,724,234	26.84%
TOTAL	17,600,000	100.00%

Directors' and Chief Executive Officer's holding in shares as at 30th September 2025

Directors Name No. of Shares %

1 Mr. Reyaz Mihular	Chairman	8,486	0.05%
2 Mr. M.N.M. Yakooth	Managing Director / CEO	1,872,053	10.64%
3 Mr. M.Y.M. Riyal	Executive Director	906,735	5.15%
4 Mr. M.N.M. Kamil		1,764,316	10.02%
5 Mr. M.N.M. Mubarak		1,826,998	10.38%
6 Mr. M.I Wahid		2,200	0.01%
7 Mr.O. A. Herath		-	0.00%
8 Ms.R. M. R. V. Ratnayake		- 0.00%
		6,380,788 36.25%
Others		11,219,212 63.75%
		17,600,000 100.00%
3 Public Holding

The percentage of shares held by the public as at 30th September 2025 is 63.7430% comprising of 3,889 shareholders. The float adjusted market capitalization as at 30th September 2025 is Rs.4,041,562,613/-

The Company complies with option 04 of the Listing Rules 7.13.1.i (a) of the Listing Rules of the Colombo Stock Exchange and the Company has complied with the minimum public holding requirement applicable under the said Option.

CORPORATE INFORMATION

Directors: Auditors:

Mr. Reyaz Mihular - Chairman Messrs. Ernst & Young Mr. M.N.M. Yakooth - Managing Director/Chief Executive Officer Chartered Accountants Mr. M.Y.M. Riyal - Executive Director Rotunda Towers

Mr. M.N.M. Kamil - Executive Director No.109

Mr. M.N.M. Mubarak - Executive Director Galle Road

Mr. M.I Wahid - Executive Director/ Operations Colombo 03 Mr.O. A. Herath - Non-Executive Director

Ms.R. M. R. V. Ratnayake - Non-Executive Director Secretaries :

P & W Corporate Secretarial (Pvt) Limited 3/17, Kynsey Road,

Registered Office: Colombo 08.

No.407, 2nd Floor,

Galle Road, Colombo 03. Registrars:

Central Depository Systems (Pvt) Ltd

Telephone : 011-2575255 ( Hunting ) Ground Floor,

Facsimile : 011-2575256 M&M Center,

E-mail : corporateoffice@bairaha.com 341/5, Kotte Road,

Web : https://www.bairaha.com Rajagiriya.

Main Bankers:

Amana Bank Plc, No. 365, Galle Road, Colombo 03.

Seylan Bank Plc Seylan Towers No. 90, Galle Road Colombo 03.

Hatton National Bank Plc No. 502/ 1A, Colpetty Road, Marine Drive,

Colombo-03.

Bank of Ceylon, Corporate Branch,

No. 4, Bank of Ceylon Mawatha Colombo 01.

Earlier from Bairaha Farms

All Bairaha Farms news releases